Biocon’s Pertuzumab biosimilar gets positive recommendation from EU committee
Mumbai: Bengaluru-based biocon announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended for granting the marketing authorisation to its Pertuzumab biosimilar. The 420 mg concentrate …